Association of serum inflammatory markers and diabetic retinopathy: a review of literature.

A. Kostakis,N. Garmpis,A. Lavaris,A. Rouvas,I. Asproudis,M. Moschos,C. Kalogeropoulos,C. Damaskos,N. Gouliopoulos,A. Garmpi
DOI: https://doi.org/10.26355/eurrev_201811_16243
2018-11-01
European review for medical and pharmacological sciences
Abstract:OBJECTIVE Diabetic retinopathy is the leading cause of irreversible blindness in the western world, among the working-age people. Its exact pathogenesis, however, remains obscure. Systemic inflammation is regarded to play a significant role in diabetes by contributing, among others, to the development of diabetic retinopathy. This review focuses on the possible involvement of the systemic inflammatory markers in the pathogenesis of diabetic retinopathy. PATIENTS AND METHODS We performed a systematic search of the literature of published papers until August 2017 using the PubMed search engine. RESULTS We demonstrated that many systemic inflammatory markers contribute to the pathogenesis and progression of retinopathy, while we highlighted in several occasions their usefulness as a key tool in the monitoring of the disease progression and the treatment efficacy. CONCLUSIONS To the best of our knowledge this is the first review in the literature that elaborates the possible association of serum inflammatory markers and diabetic retinopathy, a disease that may cause irreversible loss of vision.
Medicine
What problem does this paper attempt to address?